Showing results (21-30 of 1,986) with videos related to
Sort By:
Pageof 199
The Journal of Investigative Dermatology|July 17, 2013
A STATement on vemurafenib-resistant melanomaEdward J Hartsough, Andrew E AplinMolecular Cancer Research : MCR|June 26, 2014
Targeting TBK1 inhibits migration and resistance to MEK inhibitors in mutant NRAS melanomaHa Linh Vu, Andrew E AplinCancer Research|February 27, 2009
Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensionsR Matthew Klein, Andrew E AplinCancer Research|March 25, 2010
FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cellsEthan V Abel, Andrew E AplinThe Journal of Investigative Dermatology|November 12, 2010
Paying "particle" attention to novel melanoma treatment strategiesMichele B Weiss, Andrew E AplinPharmacology & Therapeutics|May 5, 2022
The future of targeted kinase inhibitors in melanomaSigne Caksa, Usman Baqai, Andrew E AplinThe Journal of Investigative Dermatology|October 11, 2013
Resistance to RAF inhibitors revisitedEdward Hartsough, Yongping Shao, Andrew E AplinClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Playing the Melanoma EndgameJessica L F Teh, Andrew E AplinDisease Models & Mechanisms|February 11, 2022
RAS-mediated tumor stress adaptation and the targeting opportunities it presentsAlexandra Redding, Andrew E Aplin, Elda GrabockaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2018
Arrested Developments: CDK4/6 Inhibitor Resistance and Alterations in the Tumor Immune MicroenvironmentJessica L F Teh, Andrew E AplinPageof 199